CRL

#978
Charles River Laboratories International, Inc.
179.2500 USD
+0.97%
セクター: ヘルスケア
ベース: USD
利益通貨: USD
日中レンジ
179.2500
180.4400
1年のレンジ
146.4900
228.8800
1日の変化
+0.97%
月次変化
+13.85%
6か月変化
-8.94%
1年の変化
-8.94%
以前の終値
177.5350
始値
180.2400
Bid
Ask
安値
179.2500
High
180.4400
ボリューム
305
チャート全体を表示

Financials

概要 明細書 統計
期次 年次
  • Market Capitalization 8.8241 B
  • Employee 20 K
  • Founded N/A
  • CEO James C. Foster
  • Website www.criver.com
  • Headquarter Massachusetts, United States
  • FIGI BBG000BG5BL8
  • Industry Technology
総売上高
当期純利益
1株当たり基本利益（基本EPS）
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-69.81
売上高対価格比率
2.51

Charles River Laboratories International Inc

Charles River Laboratories International, Inc. is an American pharmaceutical and biotechnology contract research organisation headquartered in Wilmington, Massachusetts, United States. Founded in 1947, the company provides preclinical and clinical laboratory services for the development of new drugs, vaccines, and medical devices. Its operations span at least 20 countries, offering research models, safety assessment, and manufacturing support services to pharmaceutical, biotechnology, and government clients. Charles River Laboratories is considered one of the largest CROs globally, known for its role in toxicology studies, animal research models, and microbial testing services used in regulatory submissions to health authorities such as the U.S. Food and Drug Administration. The company has also been the subject of public scrutiny and regulatory attention over its use of laboratory animals, including dogs, primates, and horseshoe crabs. As of 2024, the company employs over 20,000 people worldwide and is publicly traded on the New York Stock Exchange under the ticker symbol CRL.

ニュース